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The deleterious consequences of fatty acid (FA) and neutral lipid accumulation in nonadipose tissues, such as the heart,
contribute to the pathogenesis of type 2 diabetes. To elucidate mechanisms of FA-induced cell death, or lipotoxicity, we
generated Chinese hamster ovary (CHO) cell mutants resistant to palmitate-induced death and isolated a clone with
disruption of eukaryotic elongation factor (eEF) 1A-1. eEF1A-1 involvement in lipotoxicity was confirmed in H9c2
cardiomyoblasts, in which small interfering RNA-mediated knockdown also conferred palmitate resistance. In wild-type
CHO and H9c2 cells, palmitate increased reactive oxygen species and induced endoplasmic reticulum (ER) stress, changes
accompanied by increased eEF1A-1 expression. Disruption of eEF1A-1 expression rendered these cells resistant to
hydrogen peroxide- and ER stress-induced death, indicating that eEF1A-1 plays a critical role in the cell death response
to these stressors downstream of lipid overload. Disruption of eEF1A-1 also resulted in actin cytoskeleton defects under
basal conditions and in response to palmitate, suggesting that eEF1A-1 mediates lipotoxic cell death, secondary to
oxidative and ER stress, by regulating cytoskeletal changes critical for this process. Furthermore, our observations of
oxidative stress, ER stress, and induction of eEF1A-1 expression in a mouse model of lipotoxic cardiomyopathy implicate
this cellular response in the pathophysiology of metabolic disease.
INTRODUCTION
The increased prevalence of obesity worldwide has contrib-
uted to the emergence of a disease cluster, the metabolic
syndrome, that includes insulin resistance, type 2 diabetes,
and cardiovascular disease. Elevated serum triglyceride and
fatty acid (FA) levels associated with this syndrome contrib-
ute to lipid accumulation in many nonadipose tissues, in-
cluding the heart. This inappropriate accumulation of excess
lipid can lead to cellular dysfunction and cell death—a pro-
cess called lipotoxicity (Unger, 2003).
Lipotoxic cardiomyocyte death has been proposed to play
a central role in heart failure associated with diabetes and
obesity in animal models and in humans. Although FAs are
the principal source of energy for cardiomyocytes, high
serum triglyceride and FA levels result in FA uptake by the
heart that exceeds the anabolic and catabolic needs of the
tissue. Triglyceride accumulation in cardiomyocytes of lep-
tin- or leptin receptor-deficient obese diabetic animal models
is associated with cardiomyocyte apoptosis (Zhou et al.,
2000) and contractile dysfunction (Zhou et al., 2000; Aasum
et al., 2002; Christoffersen et al., 2003), suggesting that lipo-
toxic cell death in the heart may be important in the genesis
of diabetic cardiomyopathy. Recently, similar observations
were reported in patients with metabolic syndrome and
nonischemic heart failure (Sharma et al., 2004). Consistent
with this apparent cardiac lipotoxicity, cardiomyocyte-spe-
cific increases in FA uptake in mice with cardiac-restricted
overexpression of long-chain acyl-CoA synthetase 1 (ACS1),
lipoprotein lipase, or fatty acid transport protein 1 are suf-
ficient to cause cardiomyocyte abnormalities and/or death,
leading to left ventricular dysfunction (Chiu et al., 2001,
2005; Yagyu et al., 2003).
A variety of tissue culture systems have been used to
study mechanisms of lipotoxicity at the cellular level. These
studies generally implicate saturated (i.e., palmitate) rather
than unsaturated long-chain fatty acids as inducers of cell
death. Potential mechanisms of palmitate-induced cell death
include decreased cardiolipin synthesis (Ostrander et al.,
2001), increased ceramide synthesis (Shimabukuro et al.,
1998), and reactive oxygen species (ROS) generation (Shima-
bukuro et al., 1997; Listenberger et al., 2001). Decreased car-
diolipin synthesis is associated with release of cytochrome c
from the mitochondrial membrane into the cytosol, which
may initiate apoptotic signals (Ostrander et al., 2001). Recent
evidence suggests that ceramide and ROS, in contrast, trig-
ger the release of calcium ions from the endoplasmic retic-
ulum (ER) (Scorrano et al., 2003). Subsequent capture of
these ions by mitochondria initiates apoptosis.
To further understand the mechanism of palmitate-in-
duced lipotoxicity we used the ROSAgeo retroviral pro-
moter trap (Friedrich and Soriano, 1991) to perform a genetic
screen in Chinese hamster ovary (CHO) cells. Here, we
identify and characterize a mutant isolated from this screen
on the basis of resistance to palmitate-induced cell death. We
show that disruption of the gene encoding eukaryotic elon-
gation factor (eEF) 1A-1 in this mutant as well as targeted
disruption of eEF1A-1 using small interfering RNA (siRNA)
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confers resistance to palmitate-induced cell death. Further-
more, our studies support a central role for oxidative and ER
stress during FA overload-induced death in cardiomyocytes,
a mechanism that may be central to the pathogenesis of
cardiomyopathy in metabolic diseases.
MATERIALS AND METHODS
Cell Culture and Chemicals
CHO-K1 cells (American Type Culture Collection, Manassas, VA) and CHO-
derived cell lines were maintained in high glucose (4.5 mg/ml) DMEM and
Ham’s F-12 nutrient mixture (1:1), with 5% fetal bovine serum (FBS), 2 mM
l-glutamine, 50 U/ml penicillin G sodium, 50 U/ml streptomycin sulfate, and
1 mM sodium pyruvate. H9c2 rat cardiomyoblasts (American Type Culture
Collection) and H9c2-derived cell lines were maintained in high glucose
DMEM with 10% FBS, and L-glutamine, penicillin, streptomycin, and sodium
pyruvate at concentrations used in CHO cell growth medium. Wild-type
H9c2 cells were differentiated to cardiomyocyte-like cells by incubation for
5–8 d in DMEM containing 1% FBS and 10 nM all-trans-retinoic acid, as
described previously (Menard et al., 1999). For experiments, all CHO and
H9c2 cell lines (90% confluent) were incubated in CHO cell growth medium
(3.151 mg/ml glucose and 5% FBS) supplemented with palmitate (150–500
M) (Nu-Chek Prep, Elysian, MN) complexed to bovine serum albumin
(BSA) at a 2:1 M ratio (prepared as described previously; Listenberger et al.,
2001). Staurosporine, actinomycin D, cycloheximide, and camptothecin were
from Calbiochem (San Diego, CA); hydrogen peroxide (H2O2) was from
Fisher Scientific (Pittsburgh, PA); and tunicamycin, thapsigargin, and -to-
copherol were from Sigma-Aldrich (St. Louis, MO).
Generation of Palmitate-resistant CHO Cell Mutants
Vesicular stomatitis virus G protein (VSV-G) pseudotyped murine retrovirus
encoding the ROSAgeo retroviral promoter trap (Friedrich and Soriano,
1991) was generated as described previously (Ory et al., 1996). CHO cells were
transduced with retrovirus at a low multiplicity of infection to achieve an
average of one integration per 10 genomes, as determined by Southern
blotting analysis. CHO mutants were selected by growth in 0.5 mg/ml G418
(neomycin) for 8 d. Palmitate-resistant mutants were selected by growth for
2 d in media supplemented with 500 M palmitate complexed to BSA at a 2:1
M ratio. Clones were isolated by plating at limiting dilution.
Identification of Trapped Gene
The endogenous gene disrupted by retroviral integration was identified by 5
rapid amplification of cDNA ends (RACE) using primers corresponding to an
oligonucleotide tag and ROSAgeo sequences (SMART RACE cDNA ampli-
fication kit; Clontech, Mountain View, CA). The 5RACE product was subse-
quently cloned and sequenced. CHO sequence located upstream of the ret-
roviral insertion site was blasted against National Center of Biotechnology
Information databases. Directed PCR assays with primer pairs to either
wild-type CHO or wild type/retroviral fusion sequences were used to con-
firm that the sequence identified by 5RACE comprised the gene disrupted by
retroviral integration.
Northern Analysis
Total RNA was isolated using RNeasy reagents (QIAGEN, Valencia, CA).
Northern blotting was performed as described previously (Schaffer and Lo-
dish, 1994), using a 32P-labeled probe generated by SacII/EcoRI digestion of
full-length hamster eEF1A-1. A murine actin probe was used as a loading
control.
Cell Death, Caspase-3 Activity, and DNA Fragmentation
Cell death was assessed by membrane permeability to propidium iodide, as
described previously (Listenberger et al., 2001). Briefly, cells incubated for
12–24 h with various treatments were harvested by trypsinization and stained
with 1 M propidium iodide. Percentage of propidium iodide-positive cells
was determined by flow cytometry with quantification of 104 cells/sample.
Apoptosis was assessed by quantitating caspase-3 activity and DNA fragmen-
tation. Caspase-3 activity in cells incubated for 18 h with various inducers of
apoptosis was determined using a fluorometric caspase-3 assay kit (Sigma-
Aldrich). DNA cleavage in cells incubated for 24 h with various inducers of
apoptosis was assessed using a fragment end labeling kit (FragEL; Calbio-
chem). Percentage of fragment end-labeled cells was determined by flow
cytometry (5  104 cells/sample).
Targeted Knockdown of eEF1A-1 Expression
Full-length mouse eEF1A-1 cDNA sequence was used to design siRNA tem-
plate oligonucleotides using a Web-based insert design tool (www.ambion-
.com/techlib/misc/psilencer_converter.html). Hairpin siRNA template oli-
gonucleotide sequences predicted to reduce eEF1A-1 expression were used to
generate pSilencer 2.1-U6 vectors (Ambion, Austin, TX) that were transfected
into CHO and H9c2 cells. Transfected cells were selected by growth in 0.5
mg/ml hygromycin for 5 d, and clonal lines were isolated by plating at
limiting dilution. Target sequences that conferred efficient knockdown of
protein expression in these stable populations (as determined by immuno-
blotting) were 5-TATGCCTTGGTTCAAGGGA-3 and 5-CGTGTCTGT-
CAAAGATGTC-3, corresponding to nucleotides 696–714 and 1017–1035 of
the eEF1A-1 coding sequence, respectively. For each parental cell line (CHO
and H9c2), a single control siRNA-expressing clone in which eEF1A-1 expres-
sion was not reduced (designated siRNA1) and two clones in which eEF1A-1
expression was reduced to different extents (siRNA2 and siRNA3) were
maintained for further study.
Detection of Reactive Oxygen Species
Relative cellular levels of ROS were determined as described previously
(Listenberger et al., 2001), with minor modifications. CHO and H9c2 cells were
incubated for 5 h with palmitate-supplemented media. Subsequently, cells
were washed with phosphate-buffered saline (PBS) and incubated for 30 min
with PBS containing 0.5 mM MgCl2, 0.92 mM CaCl2, and 10 M 6-carboxy-
2,7-dichlorodihydrofluorescein diacetate (H2DCFDA). Cells were harvested,
resuspended in culture media, and mean fluorescence was determined by
flow cytometry (104 cells/sample).
Total Cellular Protein Synthesis
Synthesis of total cellular proteins was measured in CHO and mutant cells
after 30-min incubations with 5 Ci/ml of [35S]methionine in the absence or
presence of cycloheximide (10 g/ml). Cells were lysed in radioimmunopre-
cipitation assay (RIPA) buffer (50 mM Tris, 150 mM sodium chloride, 5 mM
EDTA, 1% Nonidet P-40, and 0.5% sodium deoxycholate), and proteins were
precipitated with 50% trichloroacetic acid (TCA). Precipitates were collected
on glass filters, and label incorporation was quantified by scintillation count-
ing and normalized for total cellular protein.
Fatty Acid Uptake
Initial rates of long chain FA uptake were determined under conditions of low
FA availability (0.6 M fatty acid and 20 M BSA) using a BODIPY-labeled
palmitate analogue, 4, 4 difluoro-5-methyl-4-bora-3a,4a-diaza-3-indacenedo-
decanoic acid (Molecular Probes, Eugene, OR), as described previously
(Schaffer and Lodish, 1994). A similar assay was performed under lipotoxic
conditions using 495 M palmitate (complexed to BSA at a molar ratio of 4:1)
and 5 M BODIPY-labeled analogue.
Microscopy
Cellular actin distribution was assessed by cytochemical staining. Wild-type
and mutant CHO cells were plated on glass coverslips, fixed with 4% form-
aldehyde, and permeabilized with Triton X-100 before staining with rhoda-
mine phalloidin (Molecular Probes). Cells were counterstained with 4,6-
diamidino-2-phenylindole (DAPI) nucleic acid stain (Molecular Probes).
Fluorescence microscopy was performed and digital images obtained using a
Zeiss Axioskop2 microscope, equipped with an AxioCamMR5 camera.
Immunoblot Analyses
Whole cell lysates were prepared using RIPA buffer. eEF1A-1 and GRP78
from 10 g of whole cell lysate protein were resolved by 10% SDS-PAGE and
detected using mouse monoclonal (CBP-KK1; Upstate Biotechnology, Lake
Placid, NY) and rabbit polyclonal (StressGen Biotechnologies, San Diego, CA)
antibodies, respectively. CHOP-10 (GADD153) from 50 g of whole cell lysate
protein was resolved by 12% SDS-PAGE and detected using a rabbit poly-
clonal antibody from Sigma-Aldrich. Subcellular fractions containing soluble
(monomeric) and insoluble (polymerized) actin were prepared by sequential
extraction with cytoskeletal stabilizing buffer (150 mM potassium chloride, 20
mM PIPES, 10 mM imidazole, 1 mM magnesium chloride, 1 mM EGTA, and
0.2 mM dithiothreitol) containing 0.05% Triton X-100 (Sigma-Aldrich) and
RIPA buffer. Actin from 5 g of protein from each fraction was detected using
a rabbit polyclonal antibody from Sigma-Aldrich. Proteins were visualized
using appropriate horseradish peroxidase-conjugated secondary antibodies
and chemiluminescence reagents (PerkinElmer Life and Analytical Sciences,
Boston, MA). Bands were quantitated by densitometry. The efficiency and
consistency of protein transfer to nitrocellulose membranes for all blots were
determined by staining with Ponceau S.
Mice
Mice overexpressing human long-chain acyl-CoA synthetase in the heart
(MHC-ACS O7) were generated previously (Chiu et al., 2001) and maintained
on a standard chow diet with 5% fat. Animals were treated in accordance with
approved Washington University Institutional Animal Care and Use Com-
mittee protocols. Animals were killed by cervical dislocation at 12 wk of age.
For analyses of protein expression, ventricular tissue was harvested, snap
frozen in liquid nitrogen, and tissue homogenates were prepared in RIPA
buffer. Homogenates were precleared with protein G, and eEF1A-1 and
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GRP78 levels were determined by SDS-PAGE and immunoblotting, as de-
scribed above. Catalase and protein disulfide isomerase (PDI) from 40 and 50
g of tissue homogenates, respectively, were resolved by 10% SDS-PAGE and
detected using rabbit polyclonal antibodies from Calbiochem and StressGen
Biotechnologies, respectively. Blots were stripped and reprobed with a rabbit
polyclonal actin antibody (Sigma-Aldrich).
RESULTS
Disruption by Insertional Mutagenesis or Targeted
Knockdown of eEF1A-1 in CHO Cells Confers Resistance
to Palmitate
To identify proteins critical for lipotoxic cell death, we per-
formed a genetic screen in CHO cells. These cells are sus-
ceptible to palmitate-induced cell death (Listenberger et al.,
2001) and are functionally hemizygous at many loci (Simi-
novitch, 1985), such that a single mutation is often sufficient
to generate a recessive phenotype. VSV-G pseudotyped ret-
rovirus encoding the ROSAgeo promoter trap (Friedrich
and Soriano, 1991) was titered and used at low multiplicity
of infection to achieve an average of less than one retroviral
integration per 10 cells. To isolate palmitate-resistant mu-
tants, ROSAgeo-trapped cells were selected in media con-
taining 500 M palmitate, conditions under which wild-type
CHO cells were killed. Sequence obtained by 5RACE of
cDNA from a palmitate-resistant clone isolated through this
screen corresponded to a portion of the 5-untranslated re-
gion (UTR) of hamster eEF1A-1 (Figure 1A). Specific disrup-
tion of eEF1A-1 by retroviral insertion was confirmed in by
directed PCR using primers for eEF1A-1, the closely related
isoform eEF1A-2, and ROSAgeo sequences (Figure 1B). A
product was obtained only in wild-type CHO cDNA using
forward and reverse primers for eEF1A-1, whereas products
were obtained in both wild-type CHO and mutant cDNA
using forward and reverse primers for eEF1A-2. A product
was obtained only in mutant cDNA using forward primer
for eEF1A-1 and reverse primer for ROSAgeo. Thus,
ROSAgeo-mediated disruption occurred only in the
eEF1A-1 gene, and only in the mutant cell line. Furthermore,
eEF1A-1 mRNA and protein expression were reduced, as
determined by Northern and immunoblotting (Figure 1, C
and D). Residual bands detected by Northern and Western
blotting in mutant cells are due to recognition of hamster
eEF1A-2 by the Northern probe and monoclonal antibody,
because eEF1A-1 and eEF1A-2 are 92% identical in amino
acid sequence (Kahns et al., 1998).
To determine whether disruption of eEF1A-1 conferred
selective resistance to palmitate, we assessed cell death and
apoptosis in wild-type CHO and mutant cells in response to
palmitate, staurosporine, actinomycin D, cycloheximide,
and camptothecin. Mutant cells were markedly resistant to
palmitate-induced cell death, but they were not resistant to
the other inducers of apoptosis (Figure 2A). Moreover, mu-
tant cells were selectively resistant to palmitate-induced ap-
optosis, as demonstrated by DNA fragmentation assays
(Figure 2B) and caspase-3 activation (Figure 1S). Thus, the
mutant cell line was not generally transformed or impaired
in its ability to undergo apoptosis and cell death.
To confirm the involvement of eEF1A-1 in palmitate-in-
duced cell death, we generated stable CHO cell lines ex-
pressing siRNA directed against eEF1A-1. Although the
knockdown of eEF1A-1 expression achieved in CHO-de-
rived cell lines was modest (14–20% in siRNA2 and siRNA3)
(Figure 2C), resistance to palmitate corresponded to the
extent of knockdown of basal eEF1A-1 protein levels (Figure
2D). Thus, targeted knockdown of eEF1A-1 produces a
palmitate-resistant phenotype similar to our CHO cell mu-
tant generated by random insertional mutagenesis, provid-
ing independent confirmation of the involvement of this
protein in palmitate-induced cell death.
Targeted Knockdown of eEF1A-1 in H9c2 Rat
Cardiomyoblasts Confers Resistance to Palmitate
To extend these findings to a cell type affected by lipotoxicity
in metabolic diseases, we investigated the role of eEF1A-1 in
palmitate toxicity in H9c2 rat cardiomyoblasts (undifferen-
tiated) and cardiomyocyte-like cultures (differentiated).
H9c2 cardiomyoblasts generated ROS within 5 h (Figure 3A)
and exhibited increased DNA fragmentation and cell death
at 24 h (Figure 3, B and C) in response to increasing doses of
palmitate. Similar trends were observed in differentiated
H9c2 cells (Figure 2S). Thus, we generated stable H9c2 car-
diomyoblast lines expressing siRNA directed against
eEF1A-1 (Figure 3D). More robust reductions in eEF1A-1
expression were achieved in H9c2-derived cell lines (56–
67% in siRNA2 and siRNA3) than in CHO-derived cell lines,
and this greater degree of knockdown was accompanied by
Figure 1. eEF1A-1 expression is disrupted in mutant CHO cells.
(A) CHO sequence upstream of the retroviral insertion was ob-
tained by 5RACE of mutant cDNA (shaded) and corresponds to
bases 1–41 of the 5UTR of hamster eEF1A-1. Rat, mouse, and
human sequences are aligned below. (B) Directed PCR for eEF1A-1
and eEF1A-2 expression in wild-type CHO and mutant cDNA.
Control reactions contained no cDNA (lanes 5 and 6). Lanes 1, 3, and
5 include forward (F) and reverse (R) primers for either eEF1A-1
(top) or eEF1A-2 (bottom). Lanes 2, 4, and 6 include forward primers
for either eEF1A-1 (top) or eEF1A-2 (bottom) and reverse primers for
the retroviral sequence (ROSAgeo). (C and D) eEF1A-1 expression
in wild-type CHO and mutant cells was assessed by Northern
blotting (C) and immunoblotting (D) using three independent RNA
and cell lysate preparations.
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greater resistance to palmitate-induced death (Figure 3E).
The extent of reduction in basal eEF1A-1 corresponded to
the extent to which the slope of the palmitate dose-response
relationship was reduced (Figure 3S). Together, data from
CHO- and H9c2-derived cell lines with targeted knockdown
of eEF1A-1 demonstrate a strong, positive correlation be-
tween basal eEF1A-1 expression and susceptibility to palmi-
tate-induced cell death (Figure 3F).
eEF1A-1 Expression Is Rapidly Induced in Response to
Palmitate and Oxidative Stress
Previous studies have demonstrated a role for eEF1A-1 in
the apoptotic response to oxidative stress (Chen et al., 2000),
and we reported previously that palmitate generates ROS in
CHO cells, leading to apoptosis and cell death (Listenberger
et al., 2001). Thus, we predicted that our mutant CHO cells
might also be resistant to H2O2-induced cell death. eEF1A-1
null CHO cells exhibited significantly elevated basal ROS
levels, which did not increase further after 5 h incubation
with palmitate (Figure 4S). This likely reflects adaptive
changes in the antioxidant and/or radical scavenging capac-
ity of these cells. However, mutant cells were markedly
resistant to cell death after 24-h incubation with 2.5 mM
H2O2 (Figure 4A), consistent with previous data showing
that H9c2 cells transfected with antisense eEF1A-1 cDNA are
protected from oxidative stress-induced death (Chen et al.,
2000). In addition, eEF1A-1 protein was rapidly induced and
remained elevated in CHO and H9c2 cells in response to
palmitate (Figure 4, B and D) or H2O2 (Figure 4C). However,
the residual, nonspecific band detected in eEF1A-1 null mu-
tant CHO cells decreased in response to palmitate (Figure
5S). These data are consistent with studies showing that
under conditions of cell stress, eEF1A-1 protein increases
posttranscriptionally to expedite apoptosis (Chen et al.,
2000), whereas eEF1A-2, which promotes cell survival, de-
creases (Ruest et al., 2002). Although the magnitude of in-
crease in eEF1A-1 expression in response to palmitate was
modest (35%), eEF1A-1 is abundant in normal growing cells,
making up 1–2% of total cellular protein (Condeelis, 1995),
and small increases in relative eEF1A-1 protein levels con-
Figure 2. Disruption by insertional mutagenesis or targeted
knockdown of eEF1A-1 in CHO cells confers palmitate-resistance.
(A) Wild-type and eEF1A-1 mutant CHO cells were incubated with
500 M palmitate (Palm), 80 nM staurosporine (Staur), 2 M acti-
nomycin D (Act D), 20 M cycloheximde (Cyclo), or 10 M camp-
tothecin (Camp) for 24 h. Cell death was determined by propidium
iodide staining and flow cytometry. (B) Cells were incubated as
described in A. Apoptosis was determined by FragEL and flow
cytometry. (C) Basal eEF1A-1 protein levels in whole cell lysates
from wild-type CHO, eEF1A-1 mutant CHO, and stable CHO-
derived cell lines expressing control siRNA (siRNA1) or siRNA
directed against eEF1A-1 (siRNA2 and siRNA3) were detected by
immunoblotting and quantified by densitometry. Inset is a repre-
sentative blot. (D) Cell lines from C were incubated for 12 h with 500
M palmitate. Cell death was determined by propidium iodide
staining and flow cytometry. All data expressed as mean  SEM for
five independent experiments, *p  0.05.
Figure 3. Targeted knockdown of eEF1A-1
expression confers palmitate-resistance in
H9c2 rat cardiomyoblasts. (A) Myoblasts
were incubated for 5 h with palmitate, fol-
lowed by 30-min incubation with H2DCFDA.
Mean DCF fluorescence, indicative of relative
cellular ROS level, was measured by flow cy-
tometry. (B) Cells were incubated for 24 h
with palmitate. Apoptosis was determined by
FragEL and flow cytometry. (C) Cells were
incubated as described in B, and cell death
was determined by propidium iodide stain-
ing and flow cytometry. (D) Basal eEF1A-1
protein levels in whole cell lysates from wild-
type H9c2 myoblast and stable H9c2-derived
cell lines expressing control siRNA (siRNA1)
or siRNA directed against eEF1A-1 (siRNA2
and siRNA3) were detected by immunoblot-
ting and quantified by densitometry. Inset is a
representative blot. (E) Cell lines from D were
incubated for 24 h with 500 M palmitate.
Cell death was determined by propidium io-
dide staining and flow cytometry. (F) Basal
eEF1A-1 expression plotted against cell death
in response to 500 M palmitate for CHO-
derived lines (wild type, mutant, and siRNA, closed symbols) and for H9c2-derived cell lines (wild type and siRNA, open symbols). All data
expressed as mean  SEM for five independent experiments, *p  0.05.
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stitute the production of large absolute quantities of this
protein. Inhibition of eEF1A-1 expression using siRNA ab-
rogated cell death in H9c2 myoblasts by preventing the
normal, toxic induction of this protein in response to palmi-
tate (Figure 6S). In summary, the induction of eEF1A-1
observed in response to palmitate or H2O2 is consistent with
a role for this protein in mediating lipotoxic cell death sec-
ondary to oxidative stress.
eEF1A-1 Mediates Cell Death in Response to
Palmitate-induced ROS Generation and ER Stress
Oxidative stress can lead to ER stress and cell death (Scor-
rano et al., 2003; Oyadomari and Mori, 2004; Rao et al., 2004),
and ER stress has been implicated in the pathogenesis of
metabolic diseases (Feng et al., 2003; Ozcan et al., 2004).
Because palmitate can induce cell death through the gener-
ation of ROS, we investigated whether eEF1A-1 mediates
lipotoxic cell death in response to ROS-induced ER stress in
cardiomyoblasts. Treatment with palmitate for 5 h induced
expression of the protein-folding chaperone glucose-regu-
lated protein 78 (GRP78), and the transcription factor
C/EBP-homologous protein CHOP-10, both markers of ER
stress (Figure 5A). These changes occurred before cell death
and concomitant with increases in cellular ROS and eEF1A-1
expression (Figure 5, A and B). Preincubation with 200 M
-tocopherol prevented palmitate-induced cellular ROS ac-
cumulation (Figure 5B); blunted palmitate-induced in-
creases in GRP78, CHOP-10, and eEF1A-1 protein (Figure
5A); and decreased cell death at 24 h (Figure 5C), suggesting
that palmitate induces ER stress and cell death through the
generation of ROS. In eEF1A-1 null CHO cells, GRP78 in-
creased to the same extent as in wild-type CHO cells in
response to palmitate (Figure 5D), indicating that the induc-
tion of an ER stress response was not impaired by disruption
of eEF1A-1. However, knockdown of eEF1A-1 in H9c2 car-
diomyoblasts (Figure 5E) and CHO cells (Figure 7S) con-
ferred resistance to cell death by the established ER stress
inducers tunicamycin and thapsigargin, consistent with a
role for eEF1A-1 in mediating ER stress-induced cell death.
Disruption of eEF1A-1 Prevents Palmitate-induced
Changes in the Actin Cytoskeleton Preceding Cell Death
We next investigated the mechanism through which
eEF1A-1 mediates palmitate-induced cell death. Because the
canonical function of eEF1A-1 is to recruit aa-tRNA to the
ribosome during peptide elongation (McKeehan and Hard-
esty, 1969), and the synthesis of new proteins is required for
apoptosis, we quantified overall protein synthesis in eEF1A-
1-deficient CHO cells. Mutant cells showed no change in
rates of [35S]methionine incorporation into TCA-precipitable
cellular proteins compared with wild-type cells (Figure 6A),
suggesting that eEF1A-2 can compensate for eEF1A-1 in
peptide elongation (Kahns et al., 1998) and that diminished
overall protein synthesis is not the mechanism for palmitate
resistance.
eEF1A-1 also plays an important role in regulating the
length and stability of cytoskeletal components, including
actin filaments (Shiina et al., 1994; Murray et al., 1996). Thus,
disruption of this protein might affect membrane events,
such as FA uptake, or cytoskeletal rearrangements involved
in the progression of cell death. eEF1A-1-deficient mutant
CHO cells showed no defect in initial rates of FA uptake
under conditions of low (physiological) FA availability or
under conditions that simulated the lipotoxic levels of FA
availability in our cell culture experiments (Figure 6B).
However, under basal conditions, mutant cells contained
40% more insoluble (polymerized) actin than wild-type
CHO cells (Figure 6, C, E, and H). Treatment with palmitate
increased polymerized actin content of wild-type CHO cells
by 17%. This effect on actin distribution is similar to changes
observed in response to H2O2 before cell death (Dalle-Donne
et al., 2001; Zhu et al., 2005). However, actin distribution
remained unchanged in mutant cells (Figure 6, C–H). Our
data are consistent with the induction of oxidative stress
during FA overload and suggest that eEF1A-1 mediates the
lipotoxic cell death response by regulating cytoskeletal
changes during cell death.
eEF1A-1 and Markers of Oxidative and ER Stress Are
Induced in a Mouse Model of Lipotoxic Cardiomyopathy
To determine whether oxidative stress, ER stress, and
eEF1A-1 are involved in lipotoxic cardiomyocyte cell death
in vivo, we assessed expression of the antioxidant enzyme
catalase (Smith et al., 2005), the ER chaperones GRP78 and
PDI, and eEF1A-1 in a mouse model of cardiac-specific
lipotoxicity. We previously generated a transgenic mouse
line with cardiac-restricted overexpression of ACS1 (MHC-
ACS O7) (Chiu et al., 2001), a protein that catalyzes the
esterification of long chain FFA to CoA, thereby facilitating
uptake. These mice exhibit cardiomyocyte lipid accumula-
tion leading to cardiomyocyte death, heart failure, and pre-
mature death. In ventricular tissue homogenates from 12-
wk-old transgenic mice, catalase, GRP78, PDI, and eEF1A-1
protein levels were increased 2.6-, 2.5-, 6.2-, and 2.8-fold,
respectively, compared with wild type (Figure 7, A and B).
Total actin levels in wild-type versus transgenic ventricular
Figure 4. eEF1A-1 expression is rapidly induced in response to
palmitate and oxidative stress. (A) Wild-type CHO and mutant cells
were incubated for 24 h with 2.5 mM H2O2 and cell death was
quantified by propidium iodide staining and flow cytometry. (B)
Wild-type CHO cells were incubated with 500 M palmitate, fol-
lowed by detection of eEF1A-1 protein levels in whole cell lysates by
immunoblotting. (C) Wild-type CHO cells were incubated with 2.5
mM H2O2, followed by detection of eEF1A-1 protein levels in whole
cell lysates by immunoblotting. (D) H9c2 cardiomyoblasts were
incubated as described in B, followed by detection of eEF1A-1
protein levels in whole cell lysates by immunoblotting. Insets are
representative blots. All data expressed as mean  SEM for five
independent experiments, *p  0.05.
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tissue homogenates were not significantly different (Figure
7A). These data further support a model in which accumu-
lation of excess lipid in the heart leads to oxidative and ER
stress, followed by induction of eEF1A-1 that contributes to
cardiomyocyte cell loss and cardiomyopathy.
DISCUSSION
Lipotoxicity has been proposed to play a role in the devel-
opment of heart failure associated with diabetes and obesity.
However, the molecular and cellular mechanisms of FA-
induced cell death are not well understood. Here, we used
the ROSAgeo promoter trap in a novel mutagenic screen in
CHO cells to identify eEF1A-1 as a key mediator of lipotoxic
cell death. Our findings are consistent with a model in which
eEF1A-1 mediates lipotoxicity secondary to oxidative and
ER stress by regulating actin cytoskeletal changes during cell
death. We extended our study to cardiomyoblasts and a
murine model of lipotoxic cardiomyopathy, pointing to a
role for this protein in the pathophysiology of metabolic
heart disease.
eEF1A-1, originally identified as the factor required for
GTP-dependent recruitment of aa-tRNA to the ribosome
during peptide elongation (McKeehan and Hardesty, 1969),
has since been shown to function in diverse cellular pro-
cesses (Ejiri, 2002), including the cytotoxic response to oxi-
dative stress in cardiomyoblasts (Chen et al., 2000). We show
here that in both CHO and H9c2 cells, palmitate rapidly
induces eEF1A-1 protein and that basal eEF1A-1 expression
dictates sensitivity to palmitate-induced cell death. eEF1A-1
may mediate specific changes in protein translation required
for palmitate-induced apoptosis and cell death. However,
cellular levels of eEF1A-1 are not rate limiting for protein
synthesis (Condeelis, 1995), and our eEF1A-1 null mutant
CHO cells do not exhibit reduced total protein synthesis,
suggesting that this protein mediates lipotoxic cell death
through a mechanism independent of changes in overall
rates of protein synthesis. In contrast, because eEF1A-1 plays
an important role in remodeling microtubules and filamen-
tous actin (Shiina et al., 1994; Murray et al., 1996) and because
the cytoskeleton undergoes dramatic changes during apo-
ptosis and cell death, eEF1A-1 may mediate cytoskeletal
changes required to execute cell death programs in response
to lipotoxic conditions. Our observation that disruption of
eEF1A-1 results in actin cytoskeleton defects under basal
conditions and in response to palmitate is consistent with a
role for eEF1A-1 in regulating FA overload-induced changes
in the actin cytoskeleton important for the progression of cell
death. Although palmitate-induced death in primary ven-
tricular cardiomyocytes is accompanied by degeneration of
myofibrils (Dyntar et al., 2001), our observation of eEF1A-1-
dependent palmitate-induced death in cell types devoid of
myofibrils suggests that this response, in contrast to actin
remodeling, is not central to the function of eEF1A-1 in
palmitate-induced cell death.
Figure 5. Palmitate-induced ROS activate an ER stress response and induce eEF1A-1 expression and cell death in cardiomyoblasts. (A)
Myoblasts were incubated for 1 h with ethanol (vehicle control) or 200 M -tocopherol, followed by 5 h with 500 M palmitate. Expression
of ER stress response proteins (GRP78 and CHOP-10) and eEF1A-1 were detected in whole cell lysates by immunoblotting. Cells incubated
for 5 h with 2.5 g/ml tunicamycin were included as a positive control. Relative densitometry values for the representative blots shown are
given below each band. Open arrow indicates a nonspecific protein band. (B) Cells were incubated as described in A, followed by incubation
for 30 min with H2DCFDA. Mean DCF fluorescence, indicative of relative cellular ROS level, was measured by flow cytometry. (C) Cells
preincubated as described in A were incubated for 24 h with or without 500 M palmitate. Cell death was determined by propidium iodide
staining and flow cytometry. (D) Wild-type (closed symbols) and eEF1A-1 null mutant (open symbols) CHO cells were incubated with 500
M palmitate. GRP78 protein levels in whole cell lysates were detected by immunoblotting. Insets are representative blots. (E) Wild-type
H9c2 myoblast and stable H9c2-derived cell lines expressing control siRNA (siRNA1) or siRNA directed against eEF1A-1 (siRNA2 and
siRNA3) were incubated for 48 h with either 2.5 g/ml tunicamycin or 1 M thapsigargin. Cell death was determined by propidium iodide
staining and flow cytometry. For B–E, data expressed as mean  SEM for at least three independent experiments, * p  0.05.
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ROS generation is likely a principal signal for cell death in
response to lipotoxic FA concentrations. Our previous stud-
ies in CHO cells demonstrated that reactive intermediates
are generated in response to palmitate supplementation
(Listenberger et al., 2001, 2003). In the present study, we
show that, in cardiomyoblasts, palmitate supplementation
leads to ROS generation before evidence of cell death. Scav-
enging palmitate-induced ROS by preincubation with -to-
copherol, a known antioxidant, reduced cell death at 24 h
after palmitate supplementation. ROS generation has been
similarly implicated in lipotoxicity in cultured pancreatic
-cells (Shimabukuro et al., 1997), endothelial cells (Inoguchi
et al., 2000), and skeletal muscle cells (Cabrero et al., 2002) as
well as in animal models of lipotoxic injury to the liver
(Browning and Horton, 2004) and heart (Finck et al., 2003).
The source of ROS generated during lipotoxicity is contro-
versial. Recent evidence, from a variety of cell types, sug-
gests that processes other than mitochondrial -oxidation,
such as NADPH oxidase activity, may be involved (Inoguchi
et al., 2003; Quagliaro et al., 2003; Cacicedo et al., 2005).
Because oxidative stress is closely linked to ER stress
(Oyadomari and Mori, 2004), we hypothesized that eEF1A-1
mediates lipotoxic cell death in response ROS-induced ER
stress in cardiomyocytes. Oxidative stress-induced apopto-
sis requires the release of ER calcium ions (Scorrano et al.,
2003), and depletion of these stores can impair normal pro-
tein-folding functions, leading to ER stress (Rao et al., 2004;
Rutkowski and Kaufman, 2004). The ER responds by acti-
vating specific pathways, including the unfolded protein
response (UPR). Initially, the UPR involves inactivation of
the translation initiation factor eIF2, through its phosphor-
ylation by an ER resident kinase (PERK), and increased
expression of protein folding chaperones, such as GRP78
Figure 6. Disruption of eEF1A-1 prevents palmitate-induced
changes in the actin cytoskeleton preceding cell death. (A) To assess
total protein synthesis, wild-type CHO and mutant cells were
pulsed for 30 min with [35S]methionine, and TCA-precipitable pro-
teins were collected. Radiolabel incorporation was quantified by
scintillation counting and normalized to total cellular protein. (B)
Initial uptake of BODIPY-labeled palmitate analogue was measured
in wild-type CHO and mutant cells under conditions of either low
(0.6 M) or lipotoxic (500 M) free FA availability. Mean fluores-
cence for each cell type was measured by flow cytometry. (C–F)
Changes in actin cytoskeleton distribution (red) were assessed by
rhodamine-phalloidin cytochemical staining and fluorescence mi-
croscopy of wild-type CHO cells under basal conditions (C) and
after 5-h incubation with palmitate (D). Identical experiments were
performed in eEF1A-1-deficient mutant CHO cells under basal con-
ditions (E) and after 5-h palmitate treatment (F). Cells were coun-
terstained with DAPI (blue). Bars, 20 m. (G and H) Subcellular
fractions containing soluble actin (G) and insoluble actin (H) were
isolated from wild-type and mutant CHO cells under basal condi-
tions and after treatment with palmitate for 5 h. Actin levels were
assessed by immunoblotting and quantitated by densitometry. In-
sets are representative blots. Data expressed as mean  SEM for
four independent experiments, *p  0.05.
Figure 7. eEF1A-1 and markers of oxidative and ER stress are
increased in lipotoxic cardiac tissue. (A) Representative immuno-
blotting of eEF1A-1, catalase, ER chaperone proteins (GRP78 and
PDI), and actin in whole tissue homogenates from ventricles of
12-wk-old wild-type or MHC-ACS mice. Blots are representative of
the four animals included in each group. Open arrow indicates
nonspecific protein bands. (B) Densitometry of immunoblotting, as
shown in A. Data expressed as mean of the protein to actin ratio 
SEM for four animals in each group, *p  0.05.
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and PDI, in a combined attempt to reduce the frequency of
translation initiation and relieve the ER of its burden of
unfolded proteins. However, when ER function is severely
impaired, apoptosis, mediated by the transcription factor
CHOP-10, ensues (Rao et al., 2004). Here we demonstrate, in
H9c2 cells, that palmitate increased cellular ROS and in-
duced GRP78, CHOP-10, and eEF1A-1 expression at 5 h,
resulting in cell death at 24 h. These effects were abrogated
by preincubation with -tocopherol. Our data suggest that
eEF1A-1 mediates lipotoxic cell death secondary to ROS-
induced ER stress (Figure 8). However, we cannot exclude
the possibility that esterification of palmitate as it enters the
cell may also directly induce ER stress, because in vitro
evidence suggests that palmitoyl CoA may facilitate ER
fission (Turner, 2004). This could lead to the release of ROS
generated through oxidative protein folding (Harding et al.,
2003), triggering apoptosis. Our data showing that disrup-
tion or knockdown of eEF1A-1 confers resistance to cell
death by tunicamycin or thapsigargin suggests that eEF1A-1
acts downstream of induction of ER stress and thus is rela-
tively distal in the pathway leading to cell death in the
presence of palmitate. Together with the observation that ER
stress is central to cholesterol-induced apoptosis in macro-
phages (Feng et al., 2003), our results are consistent with a
general model in which perturbations of lipid metabolism
can result in cell death mediated via the ER.
Oxidative and ER stress have recently been linked to the
pathogenesis of several diseases, including insulin resistance
and type 2 diabetes (Ozcan et al., 2004; Nakatani et al., 2005).
Although glucotoxicity has been implicated in oxidative
stress in diabetes (Brownlee, 2003), rodent models of poorly
controlled diabetes are characterized by pleiotropic meta-
bolic abnormalities, including high serum levels of both
glucose and FAs. Our observations in cells and in MHC-ACS
mice, a model of cardiac-specific lipotoxicity, indicate for the
first time that increased FA uptake alone is associated with
ER stress and cell death. Thus, elevated serum FAs in the
metabolic syndrome and diabetes may play a central role in
the pathogenesis of these disorders through the induction of
oxidative and ER stress. Furthermore, a scheme in which
excess FAs lead to oxidative and ER stress, followed by
induction of eEF1A-1 that regulates cytoskeletal changes
leading to cell death, may explain the increases in eEF1A-1
expression observed in skeletal muscle (Reynet and Kahn,
2001) and in renal cortex (Al-Maghrebi et al., 2004) from
diabetic animals and humans. This cellular response may
play a fundamental role in the genesis of complications of
diabetes and the metabolic syndrome.
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